See also this year's filing and all EDGAR filings for this company.
PDF Report 0001557746_2020_Aclaris_Therapeutics_Inc.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.03697237513678776, 'aggregate_val': 115285000, 'exp_sum': 119711000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 4055000, 'SellingGeneralAndAdministrativeExpense': 27156000, 'ResearchAndDevelopmentExpense': 64899000, 'remainder_Expenses': 23601000}} |
Graph
Absolute values for 0001557746, Aclaris Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 83,803,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 7,199,000 |
| 2 | PropertyPlantAndEquipmentNet | 2,470,000 |
| 3 | remainder_Assets | 4,825,000 |
| 4 | LiabilitiesCurrent | 22,432,000 |
| 5 | LiabilitiesNoncurrent | 3,736,000 |
| 6 | remainder_Liabilities | 2,217,000 |
| 7 | CostOfGoodsAndServicesSold | 4,055,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 27,156,000 |
| 9 | ResearchAndDevelopmentExpense | 64,899,000 |
| 10 | remainder_Expenses | 19,175,000 |
| 11 | remainder_Revenues | 4,227,000 |
| 12 | remainder_NetIncome | -50,296,000 |
| 13 | remainder_ComprehensiveNetIncome | 3,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 98,297,000 |
| 1 | Liabilities | 28,385,000 |
| 2 | Expenses | 115,285,000 |
| 3 | Revenues | 4,227,000 |
| 4 | StockholdersEquity | 69,912,000 |
| 5 | NetIncome | -161,354,000 |
| 6 | ComprehensiveNetIncome | -161,352,500 |
| 7 | BaseVar | 148,246,500 |
| 8 | EconomicCapitalRatio | -0.649 |
Edgar->Model Mapping
Feature Distribution
Change over Time
